http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2012031066-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9a177f0fa84b1b2134e13caa36974ce3 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-715 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6845 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C40B60-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 |
| filingDate | 2008-11-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_51f355081c4dc8a9c9ccce4d38d7d042 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_52804c149b0448379a83c9f9c709436a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2daf6a57ec836417d5ac18ef02e76cc0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ec6dee32724cafd97a22b0049c5c3426 |
| publicationDate | 2012-02-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2012031066-A |
| titleOfInvention | Novel antigen-binding molecule, method for screening target antigen-binding phage, and method for producing antigen-binding molecule against any target antigen |
| abstract | PROBLEM TO BE SOLVED: To provide a novel antigen-binding molecule (VLR) that recognizes an antigen that is not recognized by a known VLRA or VLRB, and a method for screening a target antigen-binding phage using the same. A leucine-rich repeat N-terminal adjacent region (LRRRNT), a leucine-rich repeat C-terminal adjacent region (LRRRCT), and one or more leucine-rich repeat sequences (LRR) between the LRRNT and the LRRCT. The LRRCT has a motif consisting of at least one of the following amino acid sequences (a) and (b). (A) Val-Lys-X1-Val-Asn- (X8) -Cys (B) Val-Lys-X1-Val-X1-Thr- (X7) -Cys {In the formula, X represents an arbitrary amino acid, and Xn (n is a natural number) represents an amino acid sequence composed of arbitrary amino acids X of the same or different n residues. } [Selection] Figure 4 |
| priorityDate | 2008-11-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 269.